NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 12,194,479
- Share change
- -295,206
- Total reported value
- $22,682,620
- Put/Call ratio
- 29%
- Price per share
- $1.86
- Number of holders
- 38
- Value change
- -$591,267
- Number of buys
- 15
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.6%
|
6,909,220
|
$13,127,518 | — | 31 Dec 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
574,901
|
$1,092,312 | — | 31 Dec 2023 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.21%
|
566,650
|
$1,076,635 | — | 31 Dec 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.21%
|
558,700
|
$1,061,530 | — | 31 Dec 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.2%
|
538,119
|
$1,022,000 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
516,696
|
$981,722 | — | 31 Dec 2023 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.12%
|
313,600
|
$595,840 | — | 31 Dec 2023 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.12%
|
310,499
|
$589,948 | — | 31 Dec 2023 | |
| EDBI Pte Ltd |
13F
|
Company |
0.08%
|
222,136
|
$422,058 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
191,301
|
$363,472 | — | 31 Dec 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
173,064
|
$328,822 | — | 31 Dec 2023 | |
| Aberdeen Group plc |
13F
|
Company |
0.06%
|
162,580
|
$308,902 | — | 31 Dec 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.06%
|
155,572
|
$295,000 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
145,195
|
$275,871 | — | 31 Dec 2023 | |
| Man Group plc |
13F
|
Company |
0.04%
|
110,624
|
$210,186 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
101,699
|
$193,228 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
100,065
|
$190,124 | — | 31 Dec 2023 | |
| Diametric Capital, LP |
13F
|
Company |
0.04%
|
99,295
|
$188,660 | — | 31 Dec 2023 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.03%
|
74,723
|
$141,974 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
74,029
|
$140,655 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
63,800
|
$121,000 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
42,431
|
$80,619 | — | 31 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.01%
|
36,123
|
$68,634 | — | 31 Dec 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
35,951
|
$68,307 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
34,347
|
$65,259 | — | 31 Dec 2023 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
33,550
|
$63,745 | — | 31 Dec 2023 | |
| Donald L. Hagan, LLC |
13F
|
Company |
0.01%
|
30,000
|
$57,000 | — | 31 Dec 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
29,365
|
$55,794 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
24,608
|
$46,755 | — | 31 Dec 2023 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.01%
|
23,000
|
$43,700 | — | 31 Dec 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.01%
|
19,763
|
$37,550 | — | 31 Dec 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
17,354
|
$32,000 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
15,279
|
$29,030 | — | 31 Dec 2023 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
13,598
|
$25,836 | — | 31 Dec 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0%
|
11,073
|
$21,039 | — | 31 Dec 2023 | |
| Headlands Technologies LLC |
13F
|
Company |
0%
|
7,698
|
$14,626 | — | 31 Dec 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
2,168
|
$4,119 | — | 31 Dec 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,644
|
$3,000 | — | 31 Dec 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
1,371
|
$2,604 | — | 31 Dec 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,191
|
$2,263 | — | 31 Dec 2023 | |
| Frazier Financial Advisors, LLC |
13F
|
Company |
0%
|
300
|
$570 | — | 31 Dec 2023 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
63
|
$112 | — | 31 Dec 2023 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
50
|
$95 | — | 31 Dec 2023 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2024
As of 31 Mar 2024,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,194,479 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., Caligan Partners LP, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, Temasek Holdings (Private) Ltd, GSA CAPITAL PARTNERS LLP, BOOTHBAY FUND MANAGEMENT, LLC, Exome Asset Management LLC, EDBI Pte Ltd, and abrdn plc.
This page lists
38
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
43
Q1 2024 holders
38
Holder diff
-5
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.